Metaanalysis of the Association of Smoking andPTPN22R620W Genotype on Autoantibody Status and Radiological Erosions in Rheumatoid Arthritis

Abstract

Objective.To investigate the interrelationships among smoking, protein tyrosine phosphatase non-receptor 22 (PTPN22) R620W (rs2476601) genotype, and anticitrullinated peptide antibody (ACPA) status; and among smoking,PTPN22R620W genotype, and presence of bone erosions overall and separately by ACPA status in patients with rheumatoid arthritis (RA).Methods.Six studies totaling 2680 patients with RA were included in a Mantel-Haenszel fixed-effects metaanalysis investigating ACPA status and up to 8 studies totaling 3172 patients with RA were included in a Mantel-Haenszel fixed-effects metaanalysis investigating presence of erosive damage.Results.Evidence was found for an increase in the odds of ACPA positivity for ever smoking (OR 1.56, 95% CI 1.28–1.90, p = 8.5 × 10−6), carriage of at least 1 of thePTPN22risk alleles (OR 1.50, 95% CI 1.13–2.00, p = 5.5 × 10−3) and both ever smoking and carriage of at least 1 of thePTPN22risk alleles (OR 2.22, 95% CI 1.69–2.91, p = 8.3 × 10−9). There was no evidence of an association between presence of erosive damage and smoking status or carriage ofPTPN22risk alleles when analyzed overall or separately by ACPA status.Conclusion.This metaanalysis indicates that both smoking and thePTPN22risk allele are associated with the risk of ACPA positivity. There was insufficient evidence to establish a relationship in either direction betweenPTPN22and smoking with erosive damage, despite evidence that ACPA positivity is associated with erosive damage.